Skip to content

Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis

Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04103281
Enrollment
75
Registered
2019-09-25
Start date
2020-09-01
Completion date
2026-12-31
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

In this research study we want to learn more about the characteristics of neutrophils that are present in the blood and secretions from a breathing tube of patients with sepsis. Sepsis is a severe type of infection, affecting various parts of the body. Neutrophils are a type of white blood cell that are part of the body's immune system. Even though neutrophils are important in getting rid of germs, they also may be harmful to parts of the body by causing injury in the lungs in patients with sepsis. Neutrophils can change their character in sepsis. Because of this, it is important for doctors to know what kind of neutrophils are in the blood and secretions from the breathing tube of patients with sepsis so that they can work to develop therapies to prevent these cells from being harmful.

Interventions

OTHERSepsis

Sepsis patients in the ICU with a breathing tube

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Case Inclusion Criteria: * sepsis patient in the ICU with a breathing tube Control Inclusion Criteria: * scheduled for an elective surgical procedure and need preoperative blood draw or will have an intravenous catheter placed for the purpose of their surgical procedure * Plan to have endotracheal tube for planned procedures.

Exclusion criteria

* On chronic immunosuppressive drugs such as chronic corticosteroid use, or preexisting immunodeficiency diseases (oncology patients, patients with transplantation)

Design outcomes

Primary

MeasureTime frameDescription
Neutrophil characteristicsOne daymeasure and report β2 integrin expression on neutrophils from blood and tracheal aspirate between sepsis patients and non-sepsis patients in pediatric population

Countries

United States

Contacts

CONTACTKoichi Yuki, MD
koichi.yuki@childrens.harvard.edu617-355-6225
PRINCIPAL_INVESTIGATORKoichi Yuki, MD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026